The Cancer Vaccine Launch Pad continues to deliver. The NHS is at breaking point, 1000s waiting for treatment, but these ambitious projects show better is possible. A hugely exciting step forward for lung cancer treatment, one we can hope will be lifesaving in the future.

Can a digital consent process build feedback on real world incidence of quoted risks after the event? A useful build out of tech and aid to shared decision making described by Edward St John at ICPV Summer School

It's always a pleasure to talk to Macmillan Cancer Support nurses across the entire UK, who tell us what an incredible difference our charity makes to their work. #DigitalPoverty Sadly, people affected by #Cancer is still the biggest demand on our service. 📱📲

Alongside the accompanying editorial by Richard Simcock Nicolò Battisti, MD bmjoncology.bmj.com/content/3/1/e0… 2/9

We stand on the shoulders of giants 💪💪 effort (30 years of follow up) of 🏴󠁧󠁢󠁳󠁣󠁴󠁿 #breastcancer #radonc trial Why does this long follow up matter? Because it reassures that the endpoints of interest all occur in first decade. thelancet.com/journals/lanon…

The The BMJ obit. of V Craig Jordan rightly celebrates his achievements as 'father' of Tamoxifen. But science is a team venture and Tamoxifen had a 'mother' : Dora Johnson, the chemist who first synthesised this life saving drug #womenwhocurie bmj.com/content/386/bm…

This is a fabulous testament to a great hospital. I look forward to a day when a film like this would apply to cancer care in every part of the UK

Here's a Twitter List of all the #ESMO24Ambassadors for an easy #ESMO24 follow : 👇 x.com/i/lists/183205… … Well done Jon Lim and Lizzy Smyth for 🇬🇧 representation

HOLD THE DATE The 6th Annual 'Let's Talk about Black Women and Breast Cancer Conference' will be on 12th October 2024 For details and registration follow Dr Georgette Oni

And the sun is shining in Edinburgh - looking forward to some good days of debate #CoBrCa

A compelling case to NOT move to axillary clearance if the TAD is positive after neoadjuvant chemo from Amit Goyal If no survival benefit - don’t do it! CoBrCa Congress #CoBrCa

How to treat the very small Her2+ #breastcancer Iain MacPherson gives a careful analysis of RWE and RCTs. #CoBrCa2024.